Literature DB >> 24776206

Epidemiology of atrial fibrillation in Spain in the past 20 years.

Julián Pérez-Villacastín1, Nicasio Pérez Castellano2, Javier Moreno Planas2.   

Abstract

Atrial fibrillation is the most common sustained arrhythmia. Because of its potentially serious clinical consequences (heart failure, stroke, and cognitive impairment), atrial fibrillation has important socioeconomic and health implications. This article reviews the major studies on the epidemiology of atrial fibrillation in Spain. Recent data suggest that in people older than 40 years, the prevalence of atrial fibrillation may be more than 4%. Given the current Spanish demography, these data would imply that more than 1 million people in Spain have atrial fibrillation.
Copyright © 2013 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  AF; Atrial fibrillation; ECG; Epidemiology; Epidemiología; Fibrilación auricular; HT; Incidence; Incidencia; Prevalence; Prevalencia; atrial fibrillation; electrocardiogram; hypertension

Mesh:

Year:  2013        PMID: 24776206     DOI: 10.1016/j.rec.2013.02.012

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  3 in total

1.  Improvement in the Management of Oral Anticoagulation in Patients with Atrial Fibrillation in Primary Health Care.

Authors:  África García-Roy; Ana Sarsa-Gómez; Fátima Méndez-López; Blanca Urdin-Muñoz; María Antonia Sánchez-Calavera
Journal:  Int J Environ Res Public Health       Date:  2022-05-31       Impact factor: 4.614

2.  Genetic and Metabolic Determinants of Atrial Fibrillation in a General Population Sample: The CHRIS Study.

Authors:  David B Emmert; Vladimir Vukovic; Nikola Dordevic; Christian X Weichenberger; Chiara Losi; Yuri D'Elia; Claudia Volpato; Vinicius V Hernandes; Martin Gögele; Luisa Foco; Giulia Pontali; Deborah Mascalzoni; Francisco S Domingues; Rupert Paulmichl; Peter P Pramstaller; Cristian Pattaro; Alessandra Rossini; Johannes Rainer; Christian Fuchsberger; Marzia De Bortoli
Journal:  Biomolecules       Date:  2021-11-09

3.  Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry.

Authors:  Javier Azaña Gómez; Luis M Pérez-Belmonte; Manuel Rubio-Rivas; José Bascuñana; Raúl Quirós-López; María Luisa Taboada Martínez; Esther Montero Hernandez; Fernando Roque-Rojas; Manuel Méndez-Bailón; Ricardo Gómez-Huelgas
Journal:  Med Clin (Barc)       Date:  2022-03-10       Impact factor: 1.725

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.